Janssen Pharmaceutical K.K.
Janssen Pharmaceutical K.K., a subsidiary of the global Johnson & Johnson family, is headquartered in Tokyo, Japan. Established in 1959, the company has made significant strides in the pharmaceutical industry, focusing on innovative solutions across various therapeutic areas, including oncology, immunology, and neuroscience. With a commitment to advancing healthcare, Janssen is renowned for its core products, such as treatments for chronic diseases and mental health disorders, which are distinguished by their efficacy and safety profiles. The company has solidified its market position through notable achievements, including the development of groundbreaking therapies that address unmet medical needs. Operating primarily in Japan and other key regions in Asia, Janssen Pharmaceutical K.K. continues to lead in research and development, striving to improve patient outcomes and enhance the quality of life for individuals worldwide.
DitchCarbon Score
How does Janssen Pharmaceutical K.K.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Janssen Pharmaceutical K.K.'s score of 46 is higher than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Janssen Pharmaceutical K.K.'s reported carbon emissions
Janssen Pharmaceutical K.K., headquartered in Japan, currently does not provide specific carbon emissions data or reduction targets. Without available figures, it is unclear what their current emissions levels are or the scope of their emissions (Scope 1, 2, or 3). However, the company is expected to align with industry standards for climate commitments, which typically include initiatives aimed at reducing greenhouse gas emissions and enhancing sustainability practices. As the pharmaceutical sector increasingly focuses on climate action, Janssen Pharmaceutical K.K. may be involved in broader industry efforts to mitigate climate impact, although specific commitments or targets have not been disclosed.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Janssen Pharmaceutical K.K. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
